CDC73 and Hypercalcemia: Genetic testing for mutations in the CDC73 (HRPT2) gene was negative; MEN‐1 mutations were not evaluated due to the absence of evidence of other associated tumors or familial history of hypercalcemia or MEN‐1‐associated tumors.